We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
7 Medical Stocks to Buy with Market-Beating Yields
Read MoreHide Full Article
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market. It is also one of the few sectors that have reported earnings growth in the recently concluded first quarter of 2016. Both these features appeal to dividend loving investors.
This is because the dividend paying capacity of a stock is highly dependent on its earnings growth trend and the overall health of the sector to which it belongs. A regular flow of dividends ensures that a steady income flow is generated even if the market remains volatile. Moreover, regular dividend payments demonstrate a company’s sound fundamentals as well as its underlying business strength.
Medical’s Growth Prospects Support Yield
We note that expansion into emerging markets, positive demographic trends, product innovation and continuing consolidation are some of the key growth factors for the Medical sector. These aspects will continue to help companies generate steady earnings growth in the near term.
Additionally, the weakening of the U.S. dollar against foreign currencies – which has been a drag on results for quite some time – will drive top and bottom-line growth. Moreover, the recent suspension of the controversial 2.3% medical device excise tax for two years will boost profits for the entire medical device industry, which forms a major part of the Medical sector.
These encouraging factors will certainly help the companies in the Medical space sustain their market-beating dividend yields. And investors with a penchant for high dividend yield stocks will naturally flock this sector, regardless of the sharp vicissitudes in the market.
Our Picks
We have narrowed down our search to the following medical stocks based on a good Zacks Rank and dividend yield of more than 2%.
New York-based Bristol-Myers Squibb Company (BMY - Free Report) is a global specialty biopharmaceutical company. This Zacks Rank #1 (Strong Buy) stock flaunts a dividend yield of 2.06% and has a long-term earnings growth rate of 21.5%.
Investors can also count on Pfizer Inc. (PFE - Free Report) , another Zacks Rank #1 stock. This New York-based company has a solid dividend yield of 3.44% and a long-term earnings growth rate of 5.4%.
Another large-cap Pharmaceutical stock - Johnson & Johnson (JNJ - Free Report) - is an attractive choice for dividend lovers. This Zacks Rank #2 (Buy) sports a strong dividend yield of 2.77% and a long-term earnings growth rate of 5.7%
We also prefer Abbott Laboratories (ABT - Free Report) , another Zacks Rank #2 stock. Abbott Park, IL-based Abbott has a dividend yield of 2.67% and a long-term earnings growth rate of 10%.
Beyond large-cap Pharmaceutical stocks, our search picks Digirad Corporation . The Poway, CA-based diagnostic nuclear and ultrasound imaging systems and services provider carries a Zacks Rank #2 and its current dividend yield of 3.88% is quite impressive.
Nursing Home operator and long-term healthcare services provider Kindred Healthcare Inc. is another good choice for investors. This Zacks Rank #2 stock has a dividend yield of 3.79% and a long-term earnings growth rate of 8%.
Last but not least, HEALTHSOUTH Corp. is a provider of outpatient surgery and rehabilitative healthcare services. Birmingham, AL-based HEALTHSOUTH has a Zacks Rank #2, with a dividend yield of 2.24% and a long-term earnings growth rate of 12.5%.
Conclusion
Although the sustainability of dividend yield is difficult to predict, we believe that the Medical sector’s compelling prospects will shield it against the vagaries plaguing the market. The gradually improving U.S. macro-environment and the uptick in the overall stock market on the back of a reversal in oil prices bode well for the sector.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
7 Medical Stocks to Buy with Market-Beating Yields
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market. It is also one of the few sectors that have reported earnings growth in the recently concluded first quarter of 2016. Both these features appeal to dividend loving investors.
This is because the dividend paying capacity of a stock is highly dependent on its earnings growth trend and the overall health of the sector to which it belongs. A regular flow of dividends ensures that a steady income flow is generated even if the market remains volatile. Moreover, regular dividend payments demonstrate a company’s sound fundamentals as well as its underlying business strength.
Medical’s Growth Prospects Support Yield
We note that expansion into emerging markets, positive demographic trends, product innovation and continuing consolidation are some of the key growth factors for the Medical sector. These aspects will continue to help companies generate steady earnings growth in the near term.
Additionally, the weakening of the U.S. dollar against foreign currencies – which has been a drag on results for quite some time – will drive top and bottom-line growth. Moreover, the recent suspension of the controversial 2.3% medical device excise tax for two years will boost profits for the entire medical device industry, which forms a major part of the Medical sector.
These encouraging factors will certainly help the companies in the Medical space sustain their market-beating dividend yields. And investors with a penchant for high dividend yield stocks will naturally flock this sector, regardless of the sharp vicissitudes in the market.
Our Picks
We have narrowed down our search to the following medical stocks based on a good Zacks Rank and dividend yield of more than 2%.
New York-based Bristol-Myers Squibb Company (BMY - Free Report) is a global specialty biopharmaceutical company. This Zacks Rank #1 (Strong Buy) stock flaunts a dividend yield of 2.06% and has a long-term earnings growth rate of 21.5%.
Investors can also count on Pfizer Inc. (PFE - Free Report) , another Zacks Rank #1 stock. This New York-based company has a solid dividend yield of 3.44% and a long-term earnings growth rate of 5.4%.
Another large-cap Pharmaceutical stock - Johnson & Johnson (JNJ - Free Report) - is an attractive choice for dividend lovers. This Zacks Rank #2 (Buy) sports a strong dividend yield of 2.77% and a long-term earnings growth rate of 5.7%
We also prefer Abbott Laboratories (ABT - Free Report) , another Zacks Rank #2 stock. Abbott Park, IL-based Abbott has a dividend yield of 2.67% and a long-term earnings growth rate of 10%.
Beyond large-cap Pharmaceutical stocks, our search picks Digirad Corporation . The Poway, CA-based diagnostic nuclear and ultrasound imaging systems and services provider carries a Zacks Rank #2 and its current dividend yield of 3.88% is quite impressive.
Nursing Home operator and long-term healthcare services provider Kindred Healthcare Inc. is another good choice for investors. This Zacks Rank #2 stock has a dividend yield of 3.79% and a long-term earnings growth rate of 8%.
Last but not least, HEALTHSOUTH Corp. is a provider of outpatient surgery and rehabilitative healthcare services. Birmingham, AL-based HEALTHSOUTH has a Zacks Rank #2, with a dividend yield of 2.24% and a long-term earnings growth rate of 12.5%.
Conclusion
Although the sustainability of dividend yield is difficult to predict, we believe that the Medical sector’s compelling prospects will shield it against the vagaries plaguing the market. The gradually improving U.S. macro-environment and the uptick in the overall stock market on the back of a reversal in oil prices bode well for the sector.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>